Rule Breaker Investing cover image

10 Years Later: 5 Winners in a Thinking World

Rule Breaker Investing

00:00

Celgene: Biotech Leadership and Acquisition

David and Tim discuss Celgene's Revlimid-led franchise and its 2019 acquisition by Bristol-Myers Squibb that limited future growth.

Play episode from 11:18
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app